Global Anti-Tumor Chinese Medicine Injection Market Growth 2026-2032
The global Anti-Tumor Chinese Medicine Injection market size is predicted to grow from US$ 553 million in 2025 to US$ 687 million in 2032; it is expected to grow at a CAGR of 3.2% from 2026 to 2032.
Anti-Tumor Chinese Medicine Injections are injectable formulations derived from traditional Chinese herbal medicines, developed using modern extraction, purification, and pharmaceutical technologies. Based on the principles of Traditional Chinese Medicine (TCM), these injections are primarily used as adjuvant therapies in cancer treatment. They are believed to enhance immunity, inhibit tumor cell proliferation, and reduce the adverse effects of chemotherapy and radiotherapy. Common indications include lung cancer, liver cancer, gastric cancer, and breast cancer.
United States market for Anti-Tumor Chinese Medicine Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-Tumor Chinese Medicine Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-Tumor Chinese Medicine Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-Tumor Chinese Medicine Injection players cover Jemincare, Livzon, Guizhou Yibai Pharmaceutical, Zhendong Health Industry Group, CR Sanjiu, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-Tumor Chinese Medicine Injection Industry Forecast? looks at past sales and reviews total world Anti-Tumor Chinese Medicine Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-Tumor Chinese Medicine Injection sales for 2026 through 2032. With Anti-Tumor Chinese Medicine Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Tumor Chinese Medicine Injection industry.
This Insight Report provides a comprehensive analysis of the global Anti-Tumor Chinese Medicine Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Tumor Chinese Medicine Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Tumor Chinese Medicine Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Tumor Chinese Medicine Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Tumor Chinese Medicine Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Tumor Chinese Medicine Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-Tumor Chinese Medicine Injection market?
What factors are driving Anti-Tumor Chinese Medicine Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Tumor Chinese Medicine Injection market opportunities vary by end market size?
How does Anti-Tumor Chinese Medicine Injection break out by Type, by Application?
Anti-Tumor Chinese Medicine Injections are injectable formulations derived from traditional Chinese herbal medicines, developed using modern extraction, purification, and pharmaceutical technologies. Based on the principles of Traditional Chinese Medicine (TCM), these injections are primarily used as adjuvant therapies in cancer treatment. They are believed to enhance immunity, inhibit tumor cell proliferation, and reduce the adverse effects of chemotherapy and radiotherapy. Common indications include lung cancer, liver cancer, gastric cancer, and breast cancer.
United States market for Anti-Tumor Chinese Medicine Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-Tumor Chinese Medicine Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-Tumor Chinese Medicine Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-Tumor Chinese Medicine Injection players cover Jemincare, Livzon, Guizhou Yibai Pharmaceutical, Zhendong Health Industry Group, CR Sanjiu, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-Tumor Chinese Medicine Injection Industry Forecast? looks at past sales and reviews total world Anti-Tumor Chinese Medicine Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-Tumor Chinese Medicine Injection sales for 2026 through 2032. With Anti-Tumor Chinese Medicine Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Tumor Chinese Medicine Injection industry.
This Insight Report provides a comprehensive analysis of the global Anti-Tumor Chinese Medicine Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Tumor Chinese Medicine Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Tumor Chinese Medicine Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Tumor Chinese Medicine Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Tumor Chinese Medicine Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Tumor Chinese Medicine Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Kanglaite Injection
- Shenqi Fuzheng Injection
- Aidi Injection
- Fufang Kushen Injection
- Huachan Injection
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jemincare
- Livzon
- Guizhou Yibai Pharmaceutical
- Zhendong Health Industry Group
- CR Sanjiu
What is the 10-year outlook for the global Anti-Tumor Chinese Medicine Injection market?
What factors are driving Anti-Tumor Chinese Medicine Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Tumor Chinese Medicine Injection market opportunities vary by end market size?
How does Anti-Tumor Chinese Medicine Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-Tumor Chinese Medicine Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-Tumor Chinese Medicine Injection by Country/Region, 2021, 2025 & 2032
2.2 Anti-Tumor Chinese Medicine Injection Segment by Type
2.2.1 Kanglaite Injection
2.2.2 Shenqi Fuzheng Injection
2.2.3 Aidi Injection
2.2.4 Fufang Kushen Injection
2.2.5 Huachan Injection
2.2.6 Anti-Tumor Chinese Medicine Injection Sales by Type
2.2.6.1 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
2.2.6.2 Global Anti-Tumor Chinese Medicine Injection Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Anti-Tumor Chinese Medicine Injection Sale Price by Type (2021-2026)
2.3 Anti-Tumor Chinese Medicine Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Anti-Tumor Chinese Medicine Injection Sales by Application
2.3.3.1 Global Anti-Tumor Chinese Medicine Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Anti-Tumor Chinese Medicine Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Anti-Tumor Chinese Medicine Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-Tumor Chinese Medicine Injection Breakdown Data by Company
3.1.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales by Company (2021-2026)
3.1.2 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Company (2021-2026)
3.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-Tumor Chinese Medicine Injection Revenue by Company (2021-2026)
3.2.2 Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company (2021-2026)
3.3 Global Anti-Tumor Chinese Medicine Injection Sale Price by Company
3.4 Key Manufacturers Anti-Tumor Chinese Medicine Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Tumor Chinese Medicine Injection Product Location Distribution
3.4.2 Players Anti-Tumor Chinese Medicine Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-TUMOR CHINESE MEDICINE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Anti-Tumor Chinese Medicine Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-Tumor Chinese Medicine Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-Tumor Chinese Medicine Injection Sales Growth
4.4 APAC Anti-Tumor Chinese Medicine Injection Sales Growth
4.5 Europe Anti-Tumor Chinese Medicine Injection Sales Growth
4.6 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Growth
5 AMERICAS
5.1 Americas Anti-Tumor Chinese Medicine Injection Sales by Country
5.1.1 Americas Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
5.1.2 Americas Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026)
5.2 Americas Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
5.3 Americas Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Tumor Chinese Medicine Injection Sales by Region
6.1.1 APAC Anti-Tumor Chinese Medicine Injection Sales by Region (2021-2026)
6.1.2 APAC Anti-Tumor Chinese Medicine Injection Revenue by Region (2021-2026)
6.2 APAC Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
6.3 APAC Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Tumor Chinese Medicine Injection by Country
7.1.1 Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
7.1.2 Europe Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026)
7.2 Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
7.3 Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Tumor Chinese Medicine Injection by Country
8.1.1 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Tumor Chinese Medicine Injection
10.3 Manufacturing Process Analysis of Anti-Tumor Chinese Medicine Injection
10.4 Industry Chain Structure of Anti-Tumor Chinese Medicine Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Tumor Chinese Medicine Injection Distributors
11.3 Anti-Tumor Chinese Medicine Injection Customer
12 WORLD FORECAST REVIEW FOR ANTI-TUMOR CHINESE MEDICINE INJECTION BY GEOGRAPHIC REGION
12.1 Global Anti-Tumor Chinese Medicine Injection Market Size Forecast by Region
12.1.1 Global Anti-Tumor Chinese Medicine Injection Forecast by Region (2027-2032)
12.1.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-Tumor Chinese Medicine Injection Forecast by Type (2027-2032)
12.7 Global Anti-Tumor Chinese Medicine Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jemincare
13.1.1 Jemincare Company Information
13.1.2 Jemincare Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.1.3 Jemincare Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jemincare Main Business Overview
13.1.5 Jemincare Latest Developments
13.2 Livzon
13.2.1 Livzon Company Information
13.2.2 Livzon Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.2.3 Livzon Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Livzon Main Business Overview
13.2.5 Livzon Latest Developments
13.3 Guizhou Yibai Pharmaceutical
13.3.1 Guizhou Yibai Pharmaceutical Company Information
13.3.2 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.3.3 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Guizhou Yibai Pharmaceutical Main Business Overview
13.3.5 Guizhou Yibai Pharmaceutical Latest Developments
13.4 Zhendong Health Industry Group
13.4.1 Zhendong Health Industry Group Company Information
13.4.2 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.4.3 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhendong Health Industry Group Main Business Overview
13.4.5 Zhendong Health Industry Group Latest Developments
13.5 CR Sanjiu
13.5.1 CR Sanjiu Company Information
13.5.2 CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.5.3 CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CR Sanjiu Main Business Overview
13.5.5 CR Sanjiu Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-Tumor Chinese Medicine Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-Tumor Chinese Medicine Injection by Country/Region, 2021, 2025 & 2032
2.2 Anti-Tumor Chinese Medicine Injection Segment by Type
2.2.1 Kanglaite Injection
2.2.2 Shenqi Fuzheng Injection
2.2.3 Aidi Injection
2.2.4 Fufang Kushen Injection
2.2.5 Huachan Injection
2.2.6 Anti-Tumor Chinese Medicine Injection Sales by Type
2.2.6.1 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
2.2.6.2 Global Anti-Tumor Chinese Medicine Injection Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Anti-Tumor Chinese Medicine Injection Sale Price by Type (2021-2026)
2.3 Anti-Tumor Chinese Medicine Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Anti-Tumor Chinese Medicine Injection Sales by Application
2.3.3.1 Global Anti-Tumor Chinese Medicine Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Anti-Tumor Chinese Medicine Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Anti-Tumor Chinese Medicine Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-Tumor Chinese Medicine Injection Breakdown Data by Company
3.1.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales by Company (2021-2026)
3.1.2 Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Company (2021-2026)
3.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-Tumor Chinese Medicine Injection Revenue by Company (2021-2026)
3.2.2 Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company (2021-2026)
3.3 Global Anti-Tumor Chinese Medicine Injection Sale Price by Company
3.4 Key Manufacturers Anti-Tumor Chinese Medicine Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Tumor Chinese Medicine Injection Product Location Distribution
3.4.2 Players Anti-Tumor Chinese Medicine Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-TUMOR CHINESE MEDICINE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Anti-Tumor Chinese Medicine Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-Tumor Chinese Medicine Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-Tumor Chinese Medicine Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-Tumor Chinese Medicine Injection Sales Growth
4.4 APAC Anti-Tumor Chinese Medicine Injection Sales Growth
4.5 Europe Anti-Tumor Chinese Medicine Injection Sales Growth
4.6 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Growth
5 AMERICAS
5.1 Americas Anti-Tumor Chinese Medicine Injection Sales by Country
5.1.1 Americas Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
5.1.2 Americas Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026)
5.2 Americas Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
5.3 Americas Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Tumor Chinese Medicine Injection Sales by Region
6.1.1 APAC Anti-Tumor Chinese Medicine Injection Sales by Region (2021-2026)
6.1.2 APAC Anti-Tumor Chinese Medicine Injection Revenue by Region (2021-2026)
6.2 APAC Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
6.3 APAC Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Tumor Chinese Medicine Injection by Country
7.1.1 Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
7.1.2 Europe Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026)
7.2 Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
7.3 Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Tumor Chinese Medicine Injection by Country
8.1.1 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Tumor Chinese Medicine Injection
10.3 Manufacturing Process Analysis of Anti-Tumor Chinese Medicine Injection
10.4 Industry Chain Structure of Anti-Tumor Chinese Medicine Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Tumor Chinese Medicine Injection Distributors
11.3 Anti-Tumor Chinese Medicine Injection Customer
12 WORLD FORECAST REVIEW FOR ANTI-TUMOR CHINESE MEDICINE INJECTION BY GEOGRAPHIC REGION
12.1 Global Anti-Tumor Chinese Medicine Injection Market Size Forecast by Region
12.1.1 Global Anti-Tumor Chinese Medicine Injection Forecast by Region (2027-2032)
12.1.2 Global Anti-Tumor Chinese Medicine Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-Tumor Chinese Medicine Injection Forecast by Type (2027-2032)
12.7 Global Anti-Tumor Chinese Medicine Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jemincare
13.1.1 Jemincare Company Information
13.1.2 Jemincare Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.1.3 Jemincare Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jemincare Main Business Overview
13.1.5 Jemincare Latest Developments
13.2 Livzon
13.2.1 Livzon Company Information
13.2.2 Livzon Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.2.3 Livzon Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Livzon Main Business Overview
13.2.5 Livzon Latest Developments
13.3 Guizhou Yibai Pharmaceutical
13.3.1 Guizhou Yibai Pharmaceutical Company Information
13.3.2 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.3.3 Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Guizhou Yibai Pharmaceutical Main Business Overview
13.3.5 Guizhou Yibai Pharmaceutical Latest Developments
13.4 Zhendong Health Industry Group
13.4.1 Zhendong Health Industry Group Company Information
13.4.2 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.4.3 Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhendong Health Industry Group Main Business Overview
13.4.5 Zhendong Health Industry Group Latest Developments
13.5 CR Sanjiu
13.5.1 CR Sanjiu Company Information
13.5.2 CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
13.5.3 CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CR Sanjiu Main Business Overview
13.5.5 CR Sanjiu Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Tumor Chinese Medicine Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-Tumor Chinese Medicine Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kanglaite Injection
Table 4. Major Players of Shenqi Fuzheng Injection
Table 5. Major Players of Aidi Injection
Table 6. Major Players of Fufang Kushen Injection
Table 7. Major Players of Huachan Injection
Table 8. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 9. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Table 10. Global Anti-Tumor Chinese Medicine Injection Revenue by Type (2021-2026) & ($ million)
Table 11. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2021-2026)
Table 12. Global Anti-Tumor Chinese Medicine Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Anti-Tumor Chinese Medicine Injection Sale by Application (2021-2026) & (K Units)
Table 14. Global Anti-Tumor Chinese Medicine Injection Sale Market Share by Application (2021-2026)
Table 15. Global Anti-Tumor Chinese Medicine Injection Revenue by Application (2021-2026) & ($ million)
Table 16. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2021-2026)
Table 17. Global Anti-Tumor Chinese Medicine Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Anti-Tumor Chinese Medicine Injection Sales by Company (2021-2026) & (K Units)
Table 19. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Company (2021-2026)
Table 20. Global Anti-Tumor Chinese Medicine Injection Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company (2021-2026)
Table 22. Global Anti-Tumor Chinese Medicine Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Anti-Tumor Chinese Medicine Injection Producing Area Distribution and Sales Area
Table 24. Players Anti-Tumor Chinese Medicine Injection Products Offered
Table 25. Anti-Tumor Chinese Medicine Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Anti-Tumor Chinese Medicine Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Anti-Tumor Chinese Medicine Injection Sales Market Share Geographic Region (2021-2026)
Table 30. Global Anti-Tumor Chinese Medicine Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Anti-Tumor Chinese Medicine Injection Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Country/Region (2021-2026)
Table 34. Global Anti-Tumor Chinese Medicine Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 37. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026)
Table 38. Americas Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 40. Americas Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 41. APAC Anti-Tumor Chinese Medicine Injection Sales by Region (2021-2026) & (K Units)
Table 42. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Region (2021-2026)
Table 43. APAC Anti-Tumor Chinese Medicine Injection Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 45. APAC Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 46. Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 47. Europe Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 49. Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Anti-Tumor Chinese Medicine Injection
Table 55. Key Market Challenges & Risks of Anti-Tumor Chinese Medicine Injection
Table 56. Key Industry Trends of Anti-Tumor Chinese Medicine Injection
Table 57. Anti-Tumor Chinese Medicine Injection Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Anti-Tumor Chinese Medicine Injection Distributors List
Table 60. Anti-Tumor Chinese Medicine Injection Customer List
Table 61. Global Anti-Tumor Chinese Medicine Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Anti-Tumor Chinese Medicine Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Anti-Tumor Chinese Medicine Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Anti-Tumor Chinese Medicine Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Anti-Tumor Chinese Medicine Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Anti-Tumor Chinese Medicine Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Anti-Tumor Chinese Medicine Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Anti-Tumor Chinese Medicine Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Anti-Tumor Chinese Medicine Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Anti-Tumor Chinese Medicine Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Jemincare Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 76. Jemincare Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 77. Jemincare Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Jemincare Main Business
Table 79. Jemincare Latest Developments
Table 80. Livzon Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Livzon Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 82. Livzon Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Livzon Main Business
Table 84. Livzon Latest Developments
Table 85. Guizhou Yibai Pharmaceutical Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 87. Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Guizhou Yibai Pharmaceutical Main Business
Table 89. Guizhou Yibai Pharmaceutical Latest Developments
Table 90. Zhendong Health Industry Group Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 92. Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Zhendong Health Industry Group Main Business
Table 94. Zhendong Health Industry Group Latest Developments
Table 95. CR Sanjiu Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 97. CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. CR Sanjiu Main Business
Table 99. CR Sanjiu Latest Developments
Table 1. Anti-Tumor Chinese Medicine Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-Tumor Chinese Medicine Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kanglaite Injection
Table 4. Major Players of Shenqi Fuzheng Injection
Table 5. Major Players of Aidi Injection
Table 6. Major Players of Fufang Kushen Injection
Table 7. Major Players of Huachan Injection
Table 8. Global Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 9. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Table 10. Global Anti-Tumor Chinese Medicine Injection Revenue by Type (2021-2026) & ($ million)
Table 11. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2021-2026)
Table 12. Global Anti-Tumor Chinese Medicine Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Anti-Tumor Chinese Medicine Injection Sale by Application (2021-2026) & (K Units)
Table 14. Global Anti-Tumor Chinese Medicine Injection Sale Market Share by Application (2021-2026)
Table 15. Global Anti-Tumor Chinese Medicine Injection Revenue by Application (2021-2026) & ($ million)
Table 16. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application (2021-2026)
Table 17. Global Anti-Tumor Chinese Medicine Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Anti-Tumor Chinese Medicine Injection Sales by Company (2021-2026) & (K Units)
Table 19. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Company (2021-2026)
Table 20. Global Anti-Tumor Chinese Medicine Injection Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company (2021-2026)
Table 22. Global Anti-Tumor Chinese Medicine Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Anti-Tumor Chinese Medicine Injection Producing Area Distribution and Sales Area
Table 24. Players Anti-Tumor Chinese Medicine Injection Products Offered
Table 25. Anti-Tumor Chinese Medicine Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Anti-Tumor Chinese Medicine Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Anti-Tumor Chinese Medicine Injection Sales Market Share Geographic Region (2021-2026)
Table 30. Global Anti-Tumor Chinese Medicine Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Anti-Tumor Chinese Medicine Injection Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Country/Region (2021-2026)
Table 34. Global Anti-Tumor Chinese Medicine Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 37. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026)
Table 38. Americas Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 40. Americas Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 41. APAC Anti-Tumor Chinese Medicine Injection Sales by Region (2021-2026) & (K Units)
Table 42. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Region (2021-2026)
Table 43. APAC Anti-Tumor Chinese Medicine Injection Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 45. APAC Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 46. Europe Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 47. Europe Anti-Tumor Chinese Medicine Injection Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 49. Europe Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Anti-Tumor Chinese Medicine Injection
Table 55. Key Market Challenges & Risks of Anti-Tumor Chinese Medicine Injection
Table 56. Key Industry Trends of Anti-Tumor Chinese Medicine Injection
Table 57. Anti-Tumor Chinese Medicine Injection Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Anti-Tumor Chinese Medicine Injection Distributors List
Table 60. Anti-Tumor Chinese Medicine Injection Customer List
Table 61. Global Anti-Tumor Chinese Medicine Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Anti-Tumor Chinese Medicine Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Anti-Tumor Chinese Medicine Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Anti-Tumor Chinese Medicine Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Anti-Tumor Chinese Medicine Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Anti-Tumor Chinese Medicine Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Anti-Tumor Chinese Medicine Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Anti-Tumor Chinese Medicine Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Anti-Tumor Chinese Medicine Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Anti-Tumor Chinese Medicine Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Jemincare Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 76. Jemincare Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 77. Jemincare Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Jemincare Main Business
Table 79. Jemincare Latest Developments
Table 80. Livzon Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Livzon Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 82. Livzon Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Livzon Main Business
Table 84. Livzon Latest Developments
Table 85. Guizhou Yibai Pharmaceutical Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 87. Guizhou Yibai Pharmaceutical Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Guizhou Yibai Pharmaceutical Main Business
Table 89. Guizhou Yibai Pharmaceutical Latest Developments
Table 90. Zhendong Health Industry Group Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 92. Zhendong Health Industry Group Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Zhendong Health Industry Group Main Business
Table 94. Zhendong Health Industry Group Latest Developments
Table 95. CR Sanjiu Basic Information, Anti-Tumor Chinese Medicine Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. CR Sanjiu Anti-Tumor Chinese Medicine Injection Product Portfolios and Specifications
Table 97. CR Sanjiu Anti-Tumor Chinese Medicine Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. CR Sanjiu Main Business
Table 99. CR Sanjiu Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-Tumor Chinese Medicine Injection
Figure 2. Anti-Tumor Chinese Medicine Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Tumor Chinese Medicine Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-Tumor Chinese Medicine Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-Tumor Chinese Medicine Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-Tumor Chinese Medicine Injection Sales Market Share by Country/Region (2025)
Figure 10. Anti-Tumor Chinese Medicine Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Kanglaite Injection
Figure 12. Product Picture of Shenqi Fuzheng Injection
Figure 13. Product Picture of Aidi Injection
Figure 14. Product Picture of Fufang Kushen Injection
Figure 15. Product Picture of Huachan Injection
Figure 16. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type in 2026
Figure 17. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2021-2026)
Figure 18. Anti-Tumor Chinese Medicine Injection Consumed in Hospital
Figure 19. Global Anti-Tumor Chinese Medicine Injection Market: Hospital (2021-2026) & (K Units)
Figure 20. Anti-Tumor Chinese Medicine Injection Consumed in Clinic
Figure 21. Global Anti-Tumor Chinese Medicine Injection Market: Clinic (2021-2026) & (K Units)
Figure 22. Global Anti-Tumor Chinese Medicine Injection Sale Market Share by Application (2025)
Figure 23. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application in 2026
Figure 24. Anti-Tumor Chinese Medicine Injection Sales by Company in 2026 (K Units)
Figure 25. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Company in 2026
Figure 26. Anti-Tumor Chinese Medicine Injection Revenue by Company in 2026 ($ millions)
Figure 27. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company in 2026
Figure 28. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 31. Americas Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 32. APAC Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 33. APAC Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 34. Europe Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 35. Europe Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 38. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Country in 2026
Figure 39. Americas Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Figure 40. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 41. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 42. United States Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Region in 2026
Figure 47. APAC Anti-Tumor Chinese Medicine Injection Revenue Market Share by Region (2021-2026)
Figure 48. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 49. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 50. China Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. India Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Country in 2026
Figure 58. Europe Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Figure 59. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 60. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 61. Germany Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. France Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 69. Egypt Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-Tumor Chinese Medicine Injection in 2026
Figure 75. Manufacturing Process Analysis of Anti-Tumor Chinese Medicine Injection
Figure 76. Industry Chain Structure of Anti-Tumor Chinese Medicine Injection
Figure 77. Channels of Distribution
Figure 78. Global Anti-Tumor Chinese Medicine Injection Sales Market Forecast by Region (2027-2032)
Figure 79. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Anti-Tumor Chinese Medicine Injection
Figure 2. Anti-Tumor Chinese Medicine Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Tumor Chinese Medicine Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-Tumor Chinese Medicine Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-Tumor Chinese Medicine Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-Tumor Chinese Medicine Injection Sales Market Share by Country/Region (2025)
Figure 10. Anti-Tumor Chinese Medicine Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Kanglaite Injection
Figure 12. Product Picture of Shenqi Fuzheng Injection
Figure 13. Product Picture of Aidi Injection
Figure 14. Product Picture of Fufang Kushen Injection
Figure 15. Product Picture of Huachan Injection
Figure 16. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Type in 2026
Figure 17. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Type (2021-2026)
Figure 18. Anti-Tumor Chinese Medicine Injection Consumed in Hospital
Figure 19. Global Anti-Tumor Chinese Medicine Injection Market: Hospital (2021-2026) & (K Units)
Figure 20. Anti-Tumor Chinese Medicine Injection Consumed in Clinic
Figure 21. Global Anti-Tumor Chinese Medicine Injection Market: Clinic (2021-2026) & (K Units)
Figure 22. Global Anti-Tumor Chinese Medicine Injection Sale Market Share by Application (2025)
Figure 23. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Application in 2026
Figure 24. Anti-Tumor Chinese Medicine Injection Sales by Company in 2026 (K Units)
Figure 25. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Company in 2026
Figure 26. Anti-Tumor Chinese Medicine Injection Revenue by Company in 2026 ($ millions)
Figure 27. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Company in 2026
Figure 28. Global Anti-Tumor Chinese Medicine Injection Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 31. Americas Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 32. APAC Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 33. APAC Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 34. Europe Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 35. Europe Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Anti-Tumor Chinese Medicine Injection Revenue 2021-2026 ($ millions)
Figure 38. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Country in 2026
Figure 39. Americas Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Figure 40. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 41. Americas Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 42. United States Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Region in 2026
Figure 47. APAC Anti-Tumor Chinese Medicine Injection Revenue Market Share by Region (2021-2026)
Figure 48. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 49. APAC Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 50. China Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. India Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Country in 2026
Figure 58. Europe Anti-Tumor Chinese Medicine Injection Revenue Market Share by Country (2021-2026)
Figure 59. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 60. Europe Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 61. Germany Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. France Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Anti-Tumor Chinese Medicine Injection Sales Market Share by Application (2021-2026)
Figure 69. Egypt Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Anti-Tumor Chinese Medicine Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-Tumor Chinese Medicine Injection in 2026
Figure 75. Manufacturing Process Analysis of Anti-Tumor Chinese Medicine Injection
Figure 76. Industry Chain Structure of Anti-Tumor Chinese Medicine Injection
Figure 77. Channels of Distribution
Figure 78. Global Anti-Tumor Chinese Medicine Injection Sales Market Forecast by Region (2027-2032)
Figure 79. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Anti-Tumor Chinese Medicine Injection Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Anti-Tumor Chinese Medicine Injection Revenue Market Share Forecast by Application (2027-2032)
